In: Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, vol. 253, no. 9, p. 1569-1573
|
In: International Ophthalmology, 2015, vol. 35, no. 2, p. 287-301
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 8, p. 2334-2341
|
In: Journal of Neurology, 2015, vol. 262, no. 1, p. 194-202
|
In: Immunologic Research, 2015, vol. 61, no. 1-2, p. 53-62
|
In: Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, vol. 253, no. 8, p. 1211-1216
|
In: Current Diabetes Reports, 2015, vol. 15, no. 11, p. 1-8
|
In: Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, vol. 253, no. 9, p. 1609-1617
|
In: Documenta Ophthalmologica, 2015, vol. 130, no. 3, p. 197-209
|
In: Journal of Antimicrobial Chemotherapy, 2019, vol. 74, no. 9, p. 2666–2675
Objectives: In a new experimental model of carbapenemase-producing Klebsiella pneumoniae osteomyelitis we evaluated the efficacy of colistin alone and in various combinations and examined the emergence of colistin-resistant strains and cross- resistance to host defence peptides (HDPs).Methods: KPC-99YC is a clinical strain with intermediate susceptibility to meropenem (MIC = 4 mg/L) and...
|